Concord Biotech Limited

₹1,311.20
▲ ₹87.36(6.66%)
Sector:Healthcare
Industry:Pharmaceuticals & Biotechnology
Today's LowToday's High
₹1,225.00
₹1,311.20
₹1,325.00
6.57% to low
to high 1.05%
52W Low52W High
₹987.00
₹1,311.20
₹1,615.00
24.73% downside
upside 23.17%

Factor Analysis

Quantitative risk and performance factors
Quantitative risk and performance factors

Volatility

66/100

Momentum

84/100

Value

32/100

Quality

90/100

Volatility

66/100

Momentum

84/100

Value

32/100

Quality

90/100

Key Metrics

CONCORDBIO • Latest Values

P/E

High
45.17
Price to Earnings Ratio

P/B

High
6.80
Price to Book Ratio

Div Yield

Low
0.61%
Annual Dividend Yield

Price

₹1,311.20
Latest Closing Price

P/E

High
45.17
Price to Earnings Ratio

P/B

High
6.80
Price to Book Ratio

Div Yield

Low
0.61%
Annual Dividend Yield

Price

₹1,311.20
Latest Closing Price

Performance Returns Matrix

Historical Performance
Historical Performance
1 Day
Gain
+6.66%

High volatility

1 Week
Loss
-2.08%

Regular fluctuation

1 Month
Loss
-15.96%

Weak month

3 Months
Gain
+5.02%

Average

1 Year
Loss
-14.14%

Difficult year

3 Years
Gain
+16.92%

Moderate growth

CAGR: +5.35%
5 Years
Loss
N/A

No data

1 Day
Gain
+6.66%

High volatility

1 Week
Loss
-2.08%

Regular fluctuation

1 Month
Loss
-15.96%

Weak month

3 Months
Gain
+5.02%

Average

1 Year
Loss
-14.14%

Difficult year

3 Years
Gain
+16.92%

Moderate growth

CAGR: +5.35%
5 Years
Loss
N/A

No data

Technical Analysis

Advanced technical indicators and patterns for in-depth analysis
Advanced technical indicators and patterns for in-depth analysis

Quantitative Data Matrix & Analysis

Advanced statistical analysis of volatility and risk-adjusted returns
Advanced statistical analysis of volatility and risk-adjusted returns

Relative Strength Matrix & Analysis

Performance comparison against market benchmark across multiple timeframes
Performance comparison against market benchmark across multiple timeframes

Z-Score Charts

Statistical deviation analysis showing how current values compare to historical averages
Statistical deviation analysis showing how current values compare to historical averages

Seasonality Analysis

Monthly return patterns and statistics
Monthly return patterns and statistics

Corporate Actions & Events

Upcoming dividends, results, and other corporate announcements
Upcoming dividends, results, and other corporate announcements

No upcoming events found

Sign Up to View Full Analysis

Get access to performance matrices, advanced technical indicators, seasonality patterns, and historical event timelines.

Concord Biotech Limited FAQs

Live market prices, valuation metrics, 52-week ranges, and financial information for Concord Biotech Limited.

What is the share price of Concord Biotech Limited today?

Concord Biotech Limited share price today is ₹1,311.20. The stock is currently up by 6.66% from its previous close of ₹1,229.30. Today’s trading range is ₹1,225.00 to ₹1,325.00.

What is the 52-week high and low of Concord Biotech Limited?

Concord Biotech Limited’s 52-week high is ₹1,615.00 and its 52-week low is ₹987.00. At the current price of ₹1,311.20, the stock is 18.81% below its 52-week high and 32.85% above its 52-week low.

What is the market cap of Concord Biotech Limited?

Concord Biotech Limited has a market capitalisation of approximately ₹13,717.28 crore, based on its current share price and outstanding shares. It is classified as a small-cap company.

What is the PE ratio and EPS of Concord Biotech Limited?

Concord Biotech Limited’s current P/E ratio is approximately 45.17x with an estimated trailing EPS of ₹29.03 per share.

What is the dividend yield of Concord Biotech Limited?

Concord Biotech Limited has a dividend yield of approximately 61.00% based on its latest dividend and current share price. The company paid an estimated dividend of ₹799.83 per share over the latest financial period.

What are the valuation metrics P/B and Price-to-Sales for Concord Biotech Limited?

Concord Biotech Limited currently trades at a Price-to-Book (P/B) ratio of 6.80x and a Price-to-Sales (P/S) ratio of 12.38x.